Jump to:
Polarean Imaging PLC Fundamentals
| Company Name | Polarean Imaging PLC | Last Updated | 2024-11-08 |
|---|
| Industry | Medical Devices | Sector | Healthcare |
|---|
| Shares in Issue | 1.207 bn | Market Cap | £18.71 m |
|---|
| PE Ratio | 0.00 | Dividend per Share | 0 |
|---|
| Dividend Yield | 0 | Dividend Cover | 0 |
|---|
| EPS | -$0.05 | EPS Growth (%) | 0 |
|---|
| PEG | 0 | DPS Growth (%) | 0 |
|---|
| Debt Ratio | 0.0078 | Debt Equity Ratio | 0 |
|---|
| Asset Equity Ratio | 1.2046 | Cash Equity Ratio | 0.9620 |
|---|
| Quick Ratio | 5.2448 | Current Ratio | 5.90 |
|---|
| Price To Book Value | 1.6221 | ROCE | 0 |
|---|
Polarean Imaging PLC Dividends
| Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
|---|
Polarean Imaging PLC Company Financials
| Assets | 2023 | 2022 | 2021 |
|---|
| Tangible Assets | $446,756.00 | $692,786.00 | $1.06 m |
| Intangible Assets | $969,339.00 | $1.58 m | $2.19 m |
| Investments | 0 | 0 | 0 |
| Total Fixed Assets | $1.80 m | $2.71 m | $3.26 m |
| Stocks | $2.22 m | $1.71 m | $1.43 m |
| Debtors | $369,677.00 | $109,397.00 | $119,096.00 |
| Cash & Equivalents | $6.17 m | $16.45 m | $28.87 m |
| Other Assets | 0 | 0 | 0 |
| Total Assets | $10.88 m | $22.54 m | $34.53 m |
| Liabilities | 2023 | 2022 | 2021 |
|---|
| Creditors within 1 year | $2.20 m | $2.21 m | $1.97 m |
| Creditors after 1 year | $381,878.00 | $1.02 m | $820,584.00 |
| Other Liabilities | 0 | 0 | 0 |
| Total Liabilities | $2.58 m | $3.23 m | $2.79 m |
| Net assets | $8.30 m | $19.30 m | $31.74 m |
| Equity | 2023 | 2022 | 2021 |
|---|
| Called up share capital | $104,780.00 | $103,463.00 | $101,642.00 |
| Share Premium | $59.31 m | $59.29 m | $59.02 m |
| Profit / Loss | -$11.88 m | -$13.91 m | -$14.02 m |
| Other Equity | $8.30 m | $19.30 m | $31.74 m |
| Preference & Minorities | 0 | 0 | 0 |
| Total Capital Employed | $8.30 m | $19.30 m | $31.74 m |
| Ratios | 2023 | 2022 | 2021 |
|---|
| Debt Ratio | $0.01 | $0.01 | $0.01 |
| Debt-to-Equity | $0.01 | $0.01 | $0.01 |
| Assets / Equity | 1.2046 | 1.2046 | 1.2046 |
| Cash / Equity | 0.9620 | 0.9620 | 0.9620 |
| EPS | -$0.05 | -$0.06 | -$0.06 |
| Cash Flow | 2023 | 2022 | 2021 |
|---|
| Cash from operating activities | -$10.43 m | -$12.26 m | -$12.25 m |
| Cashflow before financing | -$10.58 m | -$12.15 m | $22.81 m |
| Increase in Cash | -$10.36 m | -$12.17 m | $22.27 m |
| Income | 2023 | 2022 | 2021 |
|---|
| Turnover | $890,933.00 | $1.03 m | $1.19 m |
| Cost of sales | $555,450.00 | $684,732.00 | $677,402.00 |
| Gross Profit | $335,483.00 | $348,276.00 | $508,025.00 |
| Operating Profit | -$12.56 m | -$13.67 m | -$14.32 m |
| Pre-Tax profit | -$11.88 m | -$13.91 m | -$14.02 m |
Polarean Imaging PLC Company Background
| Sector | Healthcare |
|---|
| Activities | Polarean Imaging PLC designs and manufactures medical drug-device combination companies operating in the high-resolution medical imaging market. Its only operating segment being the development and commercialization of gas polariser devices and ancillary instruments. Geographically, it derives majority of the revenue from the United States of America and also has a presence in Canada and the United Kingdom. The company generates revenue from products and services such as Polarisers, Parts and Upgrades, Service and other revenue. Its product portfolio includes 9820 129Xe Hyperpolarizer, 9800 129Xe Hyperpolarizer, Polarean 3777 129Xe Hyperpolarizer Upgrade Module, Polarean 2881 Polarization Measurement Station,and others. |
|---|
| Latest Interim Date | 4 Sep 2024 |
|---|
| Latest Fiscal Year End Date | 28 Jun 2024 |
|---|
Polarean Imaging PLC Directors
| Appointed | Name | Position |
|---|
| 2020-02-03 | Mr. Richard Cecil Eversfield Morgan | Non-Executive Director,Chairman |
| 2021-06-08 | Mr. Robert Joseph Bertoldi | Non-Executive Director |
| 2024-07-29 | Mr. Cyrille Yann Nicolas Petit | Non-Executive Director |
| 2024-07-29 | Mr. Charles Fremont Osborne Jr | Executive Director,Chief Financial Officer |
| 2024-07-29 | Mr. Frank Maria Schulkes | Non-Executive Director |
| 2023-06-21 | Mr. Richard Hullihen | Executive Director,Chief Executive Officer |
| 2024-07-29 | Mr. Kenneth West | Non-Executive Director,Chairman |
| 2024-07-24 | Mr. Bastiaan Driehuys | Executive Director,Chief Scientific Officer |
| 2022-05-05 | Dr. Jonathan Allis | Non-Executive Director,Chairman |
| 2024-07-29 | Mr. Juergen Laucht | Non-Executive Director |
| 2024-07-29 | Dr. Christopher Richard von Jako | Executive Director,Chief Executive Officer |
| 2024-07-29 | Mr. Daniel Myron Brague | Non-Executive Director |
| 2024-07-24 | Dr. Marcella Kuhlman Ruddy, M.D. | Non-Executive Director |
| 2024-07-24 | Mr. William Taninhill Blair | Non-Executive Director |
Polarean Imaging PLC Contact Details
Polarean Imaging PLC Advisors
